A New Risk Scheme to Predict Warfarin-Associated HemorrhageMargaret C. Fang, Daniel E. Singer, Alan S. Go et al.|Journal of the American College of Cardiology|2011Cited by 851
Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial FibrillationAlan S. Go, Daniel E. Singer, Niela K. Pomernacki et al.|Circulation|2009Cited by 447
A New Risk Scheme to Predict Ischemic Stroke and Other Thromboembolism in Atrial Fibrillation: The ATRIA Study Stroke Risk ScoreDaniel E. Singer, Alan S. Go, Yuchiao Chang et al.|Journal of the American Heart Association|2013Cited by 407
Warfarin Discontinuation After Starting Warfarin for Atrial FibrillationMargaret C. Fang, Daniel E. Singer, Alan S. Go et al.|Circulation Cardiovascular Quality and Outcomes|2010Cited by 187
Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation?Daniel E. Singer, Alan S. Go, Yuchiao Chang et al.|Circulation Cardiovascular Quality and Outcomes|2009Cited by 106